Richmond, VA. (January 29, 2018) – HCA Virginia’s Levinson Heart Institute at Chippenham Hospital recently performed its 100th Transcatheter Aortic Valve Replacement (TAVR), a minimally invasive surgical procedure to treat patients with severe aortic valve stenosis and who are at greater risk of open heart surgery.
The physicians who performed the procedure included James Garnett, M.D. and Brad Matthews, M.D., of Virginia Cardiovascular Specialists along with Thomas Christopher, M.D. of Cardiothoracic Surgical Associates.
“Doing 100 cases means we’ve gained a lot of experience in a short period of time. We have excellent outcomes,” said Garnett. “TAVR is a great therapy to be able to offer less invasive treatment options for aortic stenosis. That means less pain and discomfort, a much faster recovery and most importantly it leads to significant improvement in patients’ symptoms.”
Aortic valve stenosis occurs when the heart’s aortic valve narrows and prevents blood flow from the heart to the rest of the body. A less-invasive method of treatment, TAVR repairs the diseased valve without removing it, and instead positions a replacement valve into the aortic valve’s place.
“We’re proud to have offered this revolutionary procedure for many patients who were not surgical candidates and had little or no other treatment options,” said Greg Lowe, chief executive officer of Chippenham & Johnston-Willis Hospitals. “TAVR has allowed these patients to not only survive but live an excellent quality of life.”
Traditional valve replacement usually requires open heart surgery in which the chest is surgically separated, however, TAVR is performed through small openings that leave the chest bones in place. TAVR is normally reserved for individuals for whom open heart surgery may be too risky, and allows more high-risk patients to avoid complications of major surgery. The procedure can also reduce a patient’s hospitalization stay and simplifies the recuperation period.
Chippenham Hospital first began its TAVR program in October 2015. For more information, visit our website.